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OBJECTIVE: The purpose was to assess functional (balance L–L and A–P displacement, sit-to-stand test (SST) and
Tinetti scale – balance and gait) and neurophysiological aspects (patellar and Achilles reflex and strength) relating
these responses to the BODE Index.
INTRODUCTION: The neurophysiological alterations found in patients with chronic obstructive pulmonary disease
(COPD) are associated with the severity of the disease. There is also involvement of peripheral muscle which, in
combination with neurophysiological impairment, may further compromise the functional activity of these patients.
METHODS: A cross-sectional study design was used. Twenty-two patients with moderate to very severe COPD
(.60 years) and 16 age-matched healthy volunteers served as the control group (CG). The subjects performed
spirometry and several measures of static and dynamic balance, monosynaptic reflexes, peripheral muscle strength,
SST and the 6-minute walk test.
RESULTS: The individuals with COPD had a reduced reflex response, 36.77¡3.23 (p,0.05) and 43.54¡6.60 (p,0.05),
achieved a lower number repetitions on the SST 19.27¡3.88 (p,0.05), exhibited lesser peripheral muscle strength
on the femoral quadriceps muscle, 24.98¡6.88 (p,0.05) and exhibited deficits in functional balance and gait on the
Tinetti scale, 26.86¡1.69 (p,0.05), compared with the CG. The BODE Index demonstrated correlations with balance
assessment (determined by the Tinetti scale), r = 0.59 (p,0.05) and the sit-to-stand test, r = 0.78 (p,0.05).
CONCLUSIONS: The individuals with COPD had functional and neurophysiological alterations in comparison with
the control group. The BODE Index was correlated with the Tinetti scale and the SST. Both are functional tests, easy
to administer, low cost and feasible, especially the SST. These results suggest a worse prognosis; however, more
studies are needed to identify the causes of these changes and the repercussions that could result in their activities
of daily living.
KEYWORDS: Chronic obstructive pulmonary disease; Neurophysiological aspects; BODE Index; EMG; Prognosis.
Rocco CCM, Sampaio LMM, Stirbulov R, Correˆa JCF. Neurophysiological Aspects and their relationship to clinical and functional impairment in
patients with Chronic Obstructive Pulmonary Disease. Clinics. 2011;66(1):125-129.
Received for publication on October 19, 2010; First review completed on November 1, 2010; Accepted for publication on November 25, 2010
E-mail: carolcmiranda@uol.com.br
Tel.: 55 13 3877-4715
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is char-
acterized by obstruction in airflow;1 however, COPD is a
systemic illness. Lung impairment is only one of the symp-
toms, and mechanisms such as oxidative stress and inflam-
mation may be involved in the development of the systemic
effects. The skeletal musculature is affected, and there are
alterations regarding the type of fiber and muscle mass,
enzymatic metabolism and capillarization of blood vessels.2–5
Other abnormalities are seen in these patients and are
related to neurophysiological aspects. Electromyography
(EMG) is useful in the detection of abnormal electrical
activity in muscles, in which a substantial reduction in the
speed of the reflex response may correspond to a nerve
conduction pathology, such as a peripheral neuropathy.6,7
Neurophysiological alterations, such as nerve conduction
(monosynaptic reflex test) and strength, have been corre-
lated with smoking, the severity of the disease, hypoxemia,
age, hypercapnia and peak expiratory flow.8 However,
these aspects have not been compared with functional
capacity and other predictors, such as the BODE Index (four
factors are addressed: 1. Body mass index (BMI), calculated
from the formula weight/height (kg/m2); 2. Airflow
obstruction, assessed from the FEV1 (% predicted post-
bronchodilator use) by means of spirometry; 3. Dyspnea
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scale, Modified Medical Research Council (MMRC)
Dyspnea scale; 4. 6-minute walk test (6MWT), assessment
of functional capacity as recommended by the American
Thoracic Society (ATS)), described as a survival prognosis
score for patients with COPD.9
The presence of neurophysiological alterations was first
described by Appenzeller et al. in 1968.10 Kayacan et al.
found neurophysiological alterations in 93.8% of patients
with COPD.11 Jann et al. found a slight reduction in both
nerve conduction speed and the range of action potential of
the motor unit in chronic respiratory failure, thereby
suggesting the occurrence of peripheral neuropathy.12
Functional alterations can be observed through simple
tests such as the 6MWT, sit-to-stand test (SST) and others
that measure balance, such as the Tinetti scale (balance and
gait scale) and pressure plate (L–L and A–P displacement)
and muscle strength.
The somatosensorial, visual and vestibular systems
undergo changes during aging and may subsequently offer
reduced or inappropriate feedback to the posture control
centers. The association of these changes and illnesses such
as COPD makes elderly individuals more susceptible to
balance alterations.13
Butcher et al. investigated balance, mobility and coordina-
tion in patients with COPD and found significantly lower
scores in the oxygen-dependent group. The authors point out
that balance and coordination are important elements in the
majority of activities of daily living and that the American
College of Sports Medicine recommends the assessment and
treatment of balance in patients with COPD.14 Another study
found a reduction in muscle strength, mobility and coordina-
tion in hypoxemic patients at rest.15
Peripheral muscle strength has been studied in the realm
of pulmonary rehabilitation. However, O’Shea et al. suggest
that further investigations should be carried out on the
impact of strength on functional performance in individuals
with COPD as well as the results of an increase in strength
regarding an improvement in functional activity, including
the measurement of balance.16
Other examinations have sought the same efficacy as the
walk test, but in a smaller space, thereby facilitating their
execution. One such examination is the SST. Ozalevli et al.
compared both tests and concluded that the SST determines
the functional condition of patients with moderate to severe
COPD as well as the 6MWT, while offering lesser
hemodynamic stress.17
We hypothesized that patients with COPD show a
slowing of the monosynaptic reflexes and functional
alterations compared with healthy individuals of similar
age and that this may be associated with a worse prognosis
assessed by the BODE Index.
The purpose of the present study was to assess static
(pressure plate) and dynamic balance (Tinetti scale), mono-
synaptic reflexes, peripheral muscle strength and the SST,
comparing elderly individuals with COPD with healthy
elderly individuals, then to correlate these responses with
a prognosis index of mortality, the BODE Index.
MATERIALS AND METHODS
Sample
After the statistical calculation of the sample, triage was
performed of the patients with COPD at the Pneumology
Clinic of the Santa Casa de Miserico´rdia de Sa˜o Paulo
(Brazil), from which 22 patients over 60 years of age with
moderate to very severe COPD (FEV1 #50% of predicted
post-bronchodilator use) were selected.18 The inclusion
criteria were clinical stability for at least 4 weeks prior to
the study and not having participated in any pulmonary
rehabilitation program in the previous year. The second
group of 16 healthy, but sedentary elderly individuals
made up the control group (CG). All participants should
be currently non-smokers and not have other associated
comorbidities such as asthma and neurological diseases.
The study received approval from the ethics committee
(no. 133742/2007) in Sao Paulo, Brazil. All participants were
informed as to the objectives and procedures of the study
and agreed to participate by signing terms of informed
consent.
Procedure/protocol
Supplementary oxygen was used during the walk test if
the patient exhibited a drop in SatO2 .4% of the baseline
value19 or an accentuated drop with clinical signs indicating
the use of supplementary oxygen.
Spirometry
Post-bronchodilator spirometry was performed according
to ATS standards20 at the Pulmonary Function Laboratory
prior to the other evaluations. The relative predicted values
were calculated considering the values described by
Knudson et al.21
BODE Index evaluation
This index has scores ranging from 0 (best) to 10 (worst)
and has a correlation with survival in COPD.9,19 The
following four factors are addressed: 1. Body mass index
(BMI), calculated from the formula weight/height2 (kg/m2);
2. Airflow obstruction, assessed from the FEV1 (% predicted
post-bronchodilator use) by means of spirometry;20,21 3.
Dyspnea scale, Modified Medical Research Council (MMRC)
Dyspnea scale;22 4. 6-minute walk test (6MWT), assessment
of functional capacity as recommended by the ATS.23
Evaluation tests for neurophysiological aspects
Electromyographic evaluation. An electromyograph
(EMG System, Brazil, CS 800 AF) was used. The
components of the signal acquisition system were
connected to a signal conditioner module, in which the
analogue signals amplified totaled a final gain of 1000. The
signals were filtered through a bandpass filter from 10 Hz to
500 Hz. The four pairs of active, bipolar, differential surface
electrodes with common rejection mode ratio of 80 dB were
placed on the motor point of the Retus femoris (patellar
reflex), Vastus lateralis, Tibialis anterior and Soleus
(Achilles reflex), following the recommendations of the
Project SENIAM.24 The electromyographic signal was
collected in two distinct situations – monosynaptic reflex
and peripheral muscle strength (load cell).
Monosynaptic reflex test. This was performed using a
neurological examination hammer adapted with a switch in
the percussion area for the patellar and Achilles reflexes.25
Evaluation of peripheral muscle strength. With the
patient seated, the knee was extended under resistance at
maximal strength capacity – peak isometric contraction
force of the right quadriceps was collected by means of the
load cell in kg/force.26
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Evaluation of static balance. The pressure plate
(TeKScan; MatScan model; 0.50 6 0.60 cm) was used to
analyze oscillations in pressure points in relation to speed as
well as anterior–posterior and lateral–lateral displacement.
After calibrating the system, each patient was instructed to
remain in a static position on the platform, for 60 s with the
head aligned, maintaining the distance between the feet
similar to the distance between the shoulders.27 While the
patient remained in the orthostatic position for 60 s, data
were collected at the center of pressure (COP is the point on
a body where the total sum of a pressure field acts, causing a
force and no moment about that point), and projected on the
pressure platform.
Tinetti Scale – gait and balance. The Tinetti Scale was
used for the assessment of gait as well as static and dynamic
balance. This scale consists of 16 tasks, such as Sitting
balance (without touching), Lift, Attempts to rise,
Orthostatic balance, Rotate 360 ,˚ Sit and Initiation of gait,
Stride length and height, Step symmetry, Continuity of the
steps, Posture during gait, analyzed through observations
by the examiner (maximum of 28 points – being ‘‘0’’ with
hesitation, ‘‘1’’ without a hesitation, and some items with a
score of ‘‘2’’ points for better performance and without
hesitation). Patients who achieved a score below 19 points
are considered to be at high risk of falls.28
Sit-to-Stand test. A standard chair (height 46 cm)
without armrests was used for this test. The patient was
instructed to begin the movement, standing up from and
sitting down on the chair with no support from the hands,
repeating the procedure as many times as possible within a
1-min period at a patient-defined pace at which the
participant felt safe and comfortable. The number of
repetitions was recorded.17
Statistical analysis
Statistical analysis was performed using a specific soft-
ware package (SPSS, version 16.0 for Windows). It was
determined that 14 patients were required to yield 80%
power (a=20.05) to detect a difference clinically important
between the groups using a standard deviation of the
latency time of monosynaptic reflexes, sit-to-stand test and
strength. The Kolmogorov–Smirnov test was used, and
normal distribution was determined for all data. As all data
were parametric, the Student’s t-test was used for the
comparison of means between the COPD and CG. Person’s
correlation coefficient was used to determine the degree of
association between two variables in the COPD group;
p,0.05 was considered statistically significant.
RESULTS
Thirty-eight individuals participated in the study, dis-
tributed among two distinct groups: COPD (n = 22) and CG
(n = 16) (Table 1). The groups were similar, with no
statistically significant differences regarding age, weight
and height (p.0.05). The BODE Index (total score) was not
determined for the healthy individuals (Table 1). It can be
seen in Table 1 that the CG had a mild degree of dyspnea,
probably because they were elderly and sedentary.
Evaluation of functional and neurophysiological
aspects
Regarding the functional and neurophysiological aspects,
there were statistically significant differences (p,0.05)
between the groups regarding the majority of variables
analyzed (Table 2). Thus, the CG differed significantly from
the COPD group with a lower latency time regarding
patellar and Achilles reflexes, better performance on the
SST, with a greater number of repetitions, a greater value for
peripheral muscle strength and Tinetti balance and gait
scale.
Figures 1 and 2 illustrate statistically significant strong
and moderate negative associations (p,0.05) for the Tinetti
Scale and SST respectively. Correlations were weak for the
other variables (Table 3).
DISCUSSION
The primary objective of the present study was to
determine possible functional and neurophysiological
alterations caused by COPD. As expected based on previous
studies, individuals with COPD achieved worse results in
comparison with the control group regarding the speed of
patellar and Achilles nerve conduction, number of repeti-
tions on the SST, peripheral muscle strength and also on the
Tinetti scale.8,11,12,17,18,29
Butcher et al. state that differences encountered in
balance, coordination and mobility between groups were
related to the severity of the disease.14 In the present study,
no statistically significant differences were found between
the groups regarding the platform – on which balance was
assessed through by means of A–P and L–L displacement.
Table 1 - Demographic characteristics, BODE Index and
variables that make up the BODE Index (FEV1, 6MWT,
dyspnea and BMI) of the participants.
COPD n=22 CG n=16
Male/female gender (n) 19/3 9/7
Age (years) 70 (¡6.66) 68 (¡6.56)
Weight (kg) 67.22 (¡ 2.41) 77.16 (¡18.86)
Height (m) 1.62 (¡0.06) 1.59 (¡0.09)
BODE – total score 3.66 (¡1.57) –
BODE – variables:
FEV1 (% of predicted) 39.88 (¡8.69) 130 (¡28.78)*
6MWT (m) 415.04 (¡94.01) 491.90 (¡49.52)*
Dyspnea (MMRC) 2.18 (¡0.90) 0.54 (¡0.68)*
BMI (kg/m2) 25.32 (¡3.54) 30.08 (¡6.00)*
FEV1= force expiratory volume in the 1st second; 6MWT= six-minute walk
test; MMRC=modified Medical Research Council Dyspnea scale;
BMI =body mass index.
Values are given as means and standard deviations.
*Student’s t-test (p,0.05).
Table 2 - Means and respective standard deviations
regarding neurophysiological and functional parameters.
COPD n=22 CG n=16
Patellar reflex (ms) 36.77 (¡3.23) 22.90 (¡6.41)*
Achilles reflex (ms) 43.54 (¡6.60) 19.74 (¡6.99)*
L–L displacement (cm) 1.89 (¡0.78) 1.81 (¡0.76)
A–P displacement (cm) 3.07(¡1.36) 2.75 (¡0.58)
SST 19.27 (¡3.88) 23.40 (¡3.74)*
Strength mm (kg/f) 24.98 (¡6.88) 33.00 (¡5.52)*
Tinetti 26.86 (¡1.69) 27.81 (¡0.40)*
L–L = lateral–lateral; A–P = anterior–posterior; SST = sit-to-stand test
(number of repetitions); Strength mm=muscle strength of quadriceps;
Tinetti = Tinetti balance and gait scale.
*Student’s t-test (p,0.05).
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Statistically significant differences were observed only on
the Tinetti Scale also was associated with the BODE Index.
The latency time in the patellar and Achilles reflexes was
statistically different between the CG and the COPD group.
The speed of nerve conduction may be impaired by diseases
secondary to the skeletal muscle, such as COPD.6 Appen-
zeller et al. associated these alterations with COPD in
malnourished patients.10
Kayacan et al. found neurophysiological alterations in
93.8% of patients with COPD, but reported that this high
incidence may have been due to the severity of hypoxemia
in the group studied in comparison with other studies in
which the incidence ranged from 28% to 87%.11 In the study,
the authors concluded that smoking, airflow obstruction
due to COPD and duration of the disease result in changes
in gasometric values (hypoexemia, hypercapnia, respiratory
acidosis), which can slow down the conduction speed of
peripheral nerves and cause neurophysiological alterations
in patients with COPD.
Agrawall et al. analyzed conduction speed, amplitude
and latency of motor and sensory nerves.9 The authors
obtained a 16.7% prevalence of sensory impairment and
associated the neuropathy with smoking, severity and
duration of the disease.
We did not find any study that correlated alterations in
nerve conduction speed in COPD with other variables, such
as functional tests. In the present study, there was a weak
correlation between latency time in the patellar and Achilles
reflexes with the BODE Index. The correlation graphs for
these variables demonstrate considerable variability in the
sample (coefficient of variability 10.93–37.43%), in which
individuals with the same BODE Index score had different
reflex latency times.
The SST was one of the evaluations performed for the
analysis of functional aspects. Ozalevli et al. compared the
SST with the 6MWT and found that the SST determined
functional capacity as well as the 6MWT, while offering
less hemodynamic stress for patients with COPD.17
Figure 1 - Correlation between BODE Index and Tinetti Scale in the COPD group (*p,0.05).
Figure 2 - Correlation between BODE Index and SST in the COPD group (*p,0.05).
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Furthermore, the authors found that the test was correlated
with both dyspnea and peripheral muscle strength, and not
with FEV1. We suggest that the SST can reflect a worse
prognosis for individuals with COPD because of its statis-
tically significant association with the BODE Index.
The peripheral muscle strength did differ between the
COPD group and the CG. Peripheral muscle strength is
compromised as a result of a reduction in the quadriceps
cross-sectional area as well as a reduction in both types of
muscle fibers, and has been indicated as the main predictor
of mortality in COPD.30 This suggests a significant impact of
peripheral muscle structure and function on the general
health status of patients with COPD.19,29
LIMITATIONS OF THE STUDY
Probably a larger sample could demonstrate differences
regarding static balance assessed through the platform and
show relatively stronger associations of neurophysiological
variables with the BODE Index.
CONCLUSION
The individuals with COPD had functional and neuro-
physiological alterations in comparison with the control
group. The BODE Index was correlated with the Tinetti
scale and the SST. Both are functional tests, easy to
administer, low cost and feasible, especially the SST. These
results suggest a worse prognosis; however, more studies
are needed to identify the causes of these changes and the
repercussions that could result in their activities of daily
living.
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